Citation Impact
Citing Papers
Food Intake during the Normal Activity Phase Prevents Obesity and Circadian Desynchrony in a Rat Model of Night Work
2010
Adverse metabolic and cardiovascular consequences of circadian misalignment
2009 Standout
NOTCH Signaling Is Required for Formation and Self-Renewal of Tumor-Initiating Cells and for Repression of Secretory Cell Differentiation in Colon Cancer
2010 StandoutNobel
Antitumor Effects and Biomarkers of Activity of AZD0530, a Src Inhibitor, in Pancreatic Cancer
2009
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
Mechanisms of Endocrine Resistance in Breast Cancer
2010
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation
2007
Expression of Wnt3 Activates Wnt/β-Catenin Pathway and Promotes EMT-like Phenotype in Trastuzumab-Resistant HER2-Overexpressing Breast Cancer Cells
2012
Na/K-ATPase Y260 Phosphorylation–mediated Src Regulation in Control of Aerobic Glycolysis and Tumor Growth
2018
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Transcriptional architecture of the mammalian circadian clock
2016 Standout
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
2014 StandoutNobel
Dynamic PER repression mechanisms in the Drosophila circadian clock: from on-DNA to off-DNA
2010 StandoutNobel
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies
2005 Standout
Osteoblast-Derived Cells Express Functional Glucose-Dependent Insulinotropic Peptide Receptors1
2000
Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells
2007
Microbial tryptophan catabolites in health and disease
2018 Standout
The role of postprandial releases of insulin and incretin hormones in meal-induced satiety—effect of obesity and weight reduction
2001
Microfluidic single cell arrays to interrogate signalling dynamics of individual, patient-derived hematopoietic stem cells
2009
Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist
2011
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Src kinases as therapeutic targets for cancer
2009
Cell signalling of the GLP-1 action in rat liver
2003
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
2015 StandoutNature
When brain clocks lose track of time: cause or consequence of neuropsychiatric disorders
2011 StandoutNobel
Gene Model 129 (Gm129) Encodes a Novel Transcriptional Repressor That Modulates Circadian Gene Expression
2014 StandoutNobel
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation
2010 Standout
How May GIP Enhance the Therapeutic Efficacy of GLP-1?
2020
The effects of shift work on body weight change − a systematic review of longitudinal studies
2011
Identification of Key Processes Underlying Cancer Phenotypes Using Biologic Pathway Analysis
2007
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
2015
Pancreatic α Cell-Derived Glucagon-Related Peptides Are Required for β Cell Adaptation and Glucose Homeostasis
2017
Circadian Orchestration of the Hepatic Proteome
2006
Glucagon-like peptide-1 inhibits glucagon-induced glycogenolysis in perivenous hepatocytes specifically
2003
Biology of Incretins: GLP-1 and GIP
2007 Standout
Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients
2001
Circadian clock control of the cellular response to DNA damage
2010 StandoutNobel
Tissue‐specific expression of the human receptor for glucagon‐like peptide‐I: brain, heart and pancreatic forms have the same deduced amino acid sequences
1995
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Microfluidic organs-on-chips
2014 Standout
Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects
2001
Polyphenols: food sources and bioavailability
2004 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Effects of short-term chemical ablation of the GIP receptor on insulin secretion, islet morphology and glucose homeostasis in mice
2004
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Emerging Biological Principles of Metastasis
2017 Standout
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
EMT: 2016
2016 Standout
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
‘Small Changes' to Diet and Physical Activity Behaviors for Weight Management
2013 Standout
Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes
2002
The Physiology of Glucagon-like Peptide 1
2007 Standout
Biochemical Analysis of the Canonical Model for the Mammalian Circadian Clock
2011 StandoutNobel
A clockwork web: circadian timing in brain and periphery, in health and disease
2003
Effect of GLP-1 on glucose transport and its cell signalling in human myocytes
2004
Pancreatic Cancer
2010 Standout
Future directions of bone-targeted therapy for metastatic breast cancer
2010
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1
2011
Internal desynchronization in a model of night-work by forced activity in rats
2008
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
Ghrelin: Structure and Function
2005 Standout
Cell and Molecular Biology of the Incretin Hormones Glucagon-Like Peptide-I and Glucose-Dependent Insulin Releasing Polypeptide
1995
Differential effect of protein and fat on plasma ghrelin levels in man
2003
A role for glucagon-like peptide-1 in the central regulation of feeding
1996 StandoutNature
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Gut microbiota in human metabolic health and disease
2020 Standout
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells
2013
Presence of glucagon and glucagon-like peptide-1-(7-36)amide receptors in solubilized membranes of human adipose tissue.
1993
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
New Findings on Breast Cancer Stem Cells: A Review
2015
The Effects of Exercise-Induced Weight Loss on Appetite-Related Peptides and Motivation to Eat
2010
A Meta-Analysis of the Effect of Glucagon-Like Peptide-1 (7–36) Amide on Ad Libitum Energy Intake in Humans
2001
Chronobiology, endocrinology, and energy‐ and food‐reward homeostasis
2013
Presence and characterization of glucagon-like peptide-1(7-36) amide receptors in solubilized membranes of rat adipose tissue.
1993
Cytoplasmic Localization of β-Catenin is a Marker of Poor Outcome in Breast Cancer Patients
2010
Dipeptidyl Peptidase IV Inhibition Reduces the Degradation and Clearance of GIP and Potentiates Its Insulinotropic and Antihyperglycemic Effects in Anesthetized Pigs
2001
Circadian Rhythms and Metabolic Syndrome
2010
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Advances in Targeting Src in the Treatment of Breast Cancer and Other Solid Malignancies
2010
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
GLP-1 does not acutely affect insulin sensitivity in healthy man
1996
Assessing Bias in Studies of Prognostic Factors
2013 Standout
Chemical Ablation of Gastric Inhibitory Polypeptide Receptor Action by Daily (Pro3)GIP Administration Improves Glucose Tolerance and Ameliorates Insulin Resistance and Abnormalities of Islet Structure in Obesity-Related Diabetes
2005
Control of skin cancer by the circadian rhythm
2011 StandoutNobel
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
Current Status of Src Inhibitors in Solid Tumor Malignancies
2011
Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
2009
Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling
2010
A Phase 2 Trial of Dasatinib in Patients with Advanced HER2-Positive and/or Hormone Receptor–Positive Breast Cancer
2011
PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues
2004 Standout
Circadian Clock, Cancer, and Chemotherapy
2014 StandoutNobel
The Glucagon-Like Peptides
1999
Glucagon-like peptide-1, a new hormone of the entero-insular axis
1992
The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity
1998 Standout
Aging and insulin secretion
2003
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor.
1996
Works of L. Morgan being referenced
Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells
2008
Postprandial Triacylglycerol Responses in Simulated Night and Day Shift: Gender Differences
2001
Elevated Src kinase activity attenuates tamoxifen response in vitro and is associated with poor prognosis clinically.
2009
The ageing entero-insular axis
1998
A review of the effects of exercise on appetite regulation: an obesity perspective
2008
Effect of glucagon on carbohydrate-mediated secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36 amide) (GLP-1)
1999
Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7–36) amide, on fatty acid synthesis in explants of rat adipose tissue
1991
Altered postprandial hormone and metabolic responses in a simulated shift work environment
1998
Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells
2005
Phytoestrogen Concentrations in Serum from Japanese Men and Women over Forty Years of Age
2002
Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: Inhibition by gefitinib (`Iressa', ZD1839)
2004
Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer
2006
Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells
2007
Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of β-catenin phosphorylation
2005
The Entero-Insular Axis in Polycystic Ovarian Syndrome
1996
Postprandial Triacylglycerol Responses in Simulated Night and Day Shift: Gender Differences
2001
Inhibition of carbohydrate-mediated glucagon-like peptide-I (7–36)amide secretion by circulating non-esterified fatty acids
1999
Response of circulating immunoreactive somatostatin to nutritional stimuli in normal subjects
1981